EIGR · Categories · Form 4

EIGR - SEC Form 4 insider transactions

Eiger BioPharmaceuticals Inc. (EIGR) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for EIGR

• 1008d
  SEC Form 4 filed by Choong Ingrid

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1069d
  SEC Form 4 filed by Apelian David

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1134d
  SEC Form 4 filed by Vollins James

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1176d
  SEC Form 4 filed by Mayer Eldon C. Iii

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1223d
  SEC Form 4 filed by Apelian David

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1226d
  SEC Form 4 filed by Mayer Eldon C. Iii

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1226d
  SEC Form 4 filed by Atkisson Erik

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1231d
  SEC Form 4: Dietz Thomas John bought $71,580 worth of shares (50,000 units at $1.43)

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1253d
  SEC Form 4: Murray Christine sold $6,104 worth of shares (5,000 units at $1.22), decreasing direct ownership by 31% to 11,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1260d
  SEC Form 4: Dietz Thomas John sold $26,302 worth of shares (22,500 units at $1.17), decreasing direct ownership by 52% to 21,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1260d
  SEC Form 4: Glenn Jeffrey S bought $127,950 worth of shares (100,000 units at $1.28), increasing direct ownership by 121% to 182,355 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1391d
  SEC Form 4: Apelian David sold $49,030 worth of shares (5,000 units at $9.81) as part of a pre-agreed trading plan, decreasing direct ownership by 31% to 11,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1421d
  SEC Form 4 filed by Kelly-Croswell Lisa

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1548d
  SEC Form 4: Ryali Sriram sold $12,683 worth of shares (2,266 units at $5.60), decreasing direct ownership by 5% to 41,566 units (tax liability)

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1548d
  SEC Form 4: Mayer Eldon C. Iii sold $9,275 worth of shares (1,657 units at $5.60), decreasing direct ownership by 3% to 60,468 units to cover withholding tax

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Sachdev Amit was granted 6,000 shares, increasing direct ownership by 60% to 16,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Ryali Sriram was granted 24,000 shares, increasing direct ownership by 121% to 43,832 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Sablich Kim was granted 6,000 shares

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Glenn Jeffrey S was granted 6,000 shares, increasing direct ownership by 8% to 82,355 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Mayer Eldon C. Iii was granted 16,000 shares, increasing direct ownership by 35% to 62,125 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Murray Christine was granted 6,000 shares, increasing direct ownership by 60% to 16,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Dietz Thomas John was granted 6,000 shares, increasing direct ownership by 16% to 43,500 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Apelian David was granted 6,000 shares, increasing direct ownership by 60% to 16,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Atkisson Erik was granted 6,000 shares

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Loh Evan was granted 6,000 shares, increasing direct ownership by 75% to 14,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1551d
  SEC Form 4: Cory David A was granted 47,000 shares, increasing direct ownership by 38% to 169,183 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1610d
  SEC Form 4: Mayer Eldon C. Iii sold $7,722 worth of shares (1,560 units at $4.95), decreasing direct ownership by 3% to 46,125 units to satisfy withholding obligation

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1712d
  SEC Form 4 filed by Atkisson Erik

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1775d
  SEC Form 4 filed by Mayer Eldon C. III

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1855d
  SEC Form 4 filed by Ryali Sriram

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1873d
  SEC Form 4 filed by Sablich Kim

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1884d
  SEC Form 4: John Thomas Dietz bought $21,220 worth of Common Stock (2,500 units at $8.49), increasing direct ownership by 7% to 37,500 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: P James Shaffer was granted 11,875 units of Common Stock, increasing direct ownership by 68% to 29,296 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: Amit Sachdev was granted 5,000 units of Common Stock, increasing direct ownership by 100% to 10,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: Sriram Ryali was granted 16,250 units of Common Stock, increasing direct ownership by 854% to 18,152 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: Eilene Stephana Patton was granted 11,875 units of Common Stock, increasing direct ownership by 196% to 17,948 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: Christine Murray was granted 5,000 units of Common Stock, increasing direct ownership by 100% to 10,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: Iii C. Eldon Mayer was granted 11,875 units of Common Stock, increasing direct ownership by 33% to 47,685 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: Evan Loh was granted 5,000 units of Common Stock and sold $20,280 worth of Common Stock (2,000 units at $10.14), increasing direct ownership by 60% to 8,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: S Jeffrey Glenn was granted 5,000 units of Common Stock, increasing direct ownership by 7% to 76,355 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: John Thomas Dietz was granted 5,000 units of Common Stock, increasing direct ownership by 17% to 35,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: A David Cory was granted 47,000 units of Common Stock, increasing direct ownership by 66% to 117,846 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
• 1912d
  SEC Form 4: David Apelian was granted 5,000 units of Common Stock, increasing direct ownership by 100% to 10,000 units

  4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)

Other EIGR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends